Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 7 Results

Title
Intervention Indication Therapeutic Area Year Actions
Acalabrutinib with bendamustine and rituximab for treating previously untreated mantle cell lymphoma Acalabrutinib (Calquence; ACP-196) , Bendamustine (Treanda; EP-3102; Levact; Ribomustin; bendamustine hydrochloride monohydrate; bendamustine hydrochloride) , Rituximab (MabThera; Rituxan; RG 105) Mantle cell lymphoma Haematological Cancer and Lymphomas 2022 View  |  Download
Belimumab in combination with rituximab for systemic lupus erythematosus (SLE) Belimumab (Benlysta; Lymphostat-B) , Rituximab (MabThera; Rituxan; RG 105) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Lenalidomide (Revlimid) + rituximab for relapsed/refractory follicular lymphoma and marginal zone lymphoma Lenalidomide (Revlimid) , Rituximab (MabThera; Rituxan; RG 105) Follicular lymphoma , Marginal zone lymphoma (MZL) Haematological Cancer and Lymphomas 2017 View  |  Download
Lenalidomide (Revlimid) in combination with rituximab for untreated follicular lymphoma Lenalidomide (Revlimid) , Rituximab (MabThera; Rituxan; RG 105) Follicular lymphoma Haematological Cancer and Lymphomas 2017 View  |  Download
Polatuzumab vedotin in combination with rituximab and bendamustine for the treatment of diffuse large B-cell lymphoma Bendamustine (Treanda; EP-3102; Levact; Ribomustin; bendamustine hydrochloride monohydrate; bendamustine hydrochloride) , Polatuzumab vedotin (DCDS4501A; RG7596; RG-7596; Polivy) , Rituximab (MabThera; Rituxan; RG 105) Diffuse large B-cell lymphoma (DLBCL) Haematological Cancer and Lymphomas 2018 View  |  Download
Rituximab (MabThera) maintenance therapy for granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) Rituximab (MabThera; Rituxan; RG 105) Granulomatosis with polyangiitis (GPA) , Microscopic polyangiitis (MPA) Cardiovascular System 2017 View  |  Download
Rituximab for Pemphigus Vulgaris Rituximab (MabThera; Rituxan; RG 105) Pemphigus vulgaris Dermatology , Immunology 2018 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications